Influence of haemorrhagic transformation on the outcome of thrombolytic therapy for patients with acute brain embolism.
Okada
Y
Y
Department of Cerebrovascular Disease, St. Mary's Hospital, Kurume, Japan.
Sadoshima
S
S
Saku
Y
Y
Kitazono
T
T
Irie
K
K
Ogasawara
T
T
Utsunomiya
H
H
Fujishima
M
M
D000368:Aged; D002543:Cerebral Hemorrhage / Q000000981:diagnostic imaging / Q000209:etiology* / Q000503:physiopathology; D002544:Cerebral Infarction / Q000000981:diagnostic imaging / Q000209:etiology; D002560:Cerebrovascular Circulation; D005260:Female; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D009460:Neurologic Examination; D011994:Recombinant Proteins / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator